Obesity May Increase Risk of Long-term COVID-19 Problems

Translate to Spanish or other 102 languages!

According to recent Cleveland Clinic research, the risk for long-term COVID-19 complications may be higher for those who suffer from obesity. Image for illustration purposes

Mega Doctor News

- Advertisement -

Cleveland Clinic – Some COVID-19 survivors can struggle with lingering medical problems for months.

According to recent Cleveland Clinic research, the risk for these long-term COVID-19 complications may be higher for those who suffer from obesity.

“Patients who had moderate or severe obesity had 30% greater risk of developing these chronic consequences of disease,” said lead author Ali Aminian, MD, of Cleveland Clinic.

- Advertisement -

Dr. Aminian and his team studied a registry of nearly 3,000 people who survived COVID-19 and followed them until January 2021.

Results show chronic complications from COVID-19 are extremely common — about 40% of people who survived the disease had subsequent chronic problems.

Results also show risk for hospital admission after the initial phase of COVID-19 was about 30% higher in people with moderate-to-severe obesity.  

Other studies have shown obesity as a risk factor for developing a severe form of COVID-19 that may require hospital admission, intensive care, and ventilator support in the early phase of the disease.

- Advertisement -

Dr. Aminian said the best way to avoid COVID-19 and the chronic problems that may follow is vaccination.

“We know vaccines are extremely effective in protecting patients with obesity to reduce their risk of contracting disease. So, knowing that these patients are at greater risk for developing complications, we can say that vaccines are essential in these patients, so we need to encourage patients with obesity to get vaccinated,” he explained.

Dr. Aminian’s research is ongoing as he looks to determine the type of long-term follow-up care people with obesity need after a COVID-19 infection.

Complete study results can be found in the Journal of Diabetes, Obesity and Metabolism.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.

STHS Scores Fourth Consecutive 5-Star Rating for Diabetic Care

Diabetes remains one of the nation’s most pressing health challenges, with a disease once largely associated with older adults now affecting younger populations at an alarming rate.

STHS to Examine Back Pain in New “South Texas Healthy Living” Episode, Aug, 30th

Back pain is the most common pain condition reported by Americans, affecting nearly 65 million U.S. adults annually, with an estimated 16 million living with chronic symptoms, according to the Centers for Disease Control and Prevention (CDC).

Physicians Urge Updating Child Vaccinations Before School Starts

Texas physicians have an important message for parents as the new school year is about to begin: Ensure your children are current on all their necessary vaccinations. 
- Advertisement -